Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Pouchitis is a common complication following proctocolectomy with ileal pouch anal anastomosis (IPAA) in patients with ulcerative colitis (UC). It affects the quality of life and can become a chronic problem. The aetiology of pouchitis is not completely understood. A crucial role of the intestinal microbiota has been suggested, but no causative agent has been identified so far. Furthermore, the defensin expression and the epithelial integrity are altered in inflammatory bowel diseases and may play an important role in the development of intestinal inflammation. Therefore, it has been hypothesized that the interaction between an altered microbiota composition, a defective epithelial integrity and changes in innate defense parameters such as defensins has a pivotal role in the development of pouchitis in UC patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ulcerative colitis patients with a pouch |
|
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Differences in the intestinal microbiota composition between pouch patients with and without pouchitis | A phylogenetic microarray will be used to characterize the luminal and mucosal microbiota composition (based on the SSU rRNA gene)of pouch patients with and without pouchitis. Anticipated results are the identification of specific bacterial profiles, genera and/or species dat are discriminating between subgroups. | 24 months. |
| Measure | Description | Time Frame |
|---|---|---|
| The expression of defensins in the intestinal mucosa | The mRNA expression levels of human alfa and beta-defensins in intestinal mucosal biopsies will be assessed by real time PCR | 24 months |
| The intestinal permeability |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Consecutive patients undergoing proctocolectomy with the construction of an ileal pouch anal anastomosis will be asked to participate in the study
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| D. Jonkers, PhD | Contact | *31-43-3875021 | d.jonkers@intmed.unimaas.nl | |
| M. Pierik, PhD MD | Contact | *31-43-3875021 | m.pierik@mumc.nl |
| Name | Affiliation | Role |
|---|---|---|
| A. Masclee, Prof MD PhD | Maastricht University Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Maastricht University Medical Center, div. Gastroenterology-Hepatology | Maastricht | Limburg | 6226AZ | Netherlands |
Not provided
| ID | Term |
|---|---|
| D019449 | Pouchitis |
| D003093 | Colitis, Ulcerative |
| ID | Term |
|---|---|
| D007079 | Ileitis |
| D004751 | Enteritis |
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
In the prospective study the following biospecimens will be collected: faeces, serum, plasma, leucocytes, urine, intestinal biopsies and mucus
The epithelial integrity will be studied by the multiple sugar test to assess small intestinal and whole gut permeability.
| 24 months. |
| Inflammatory mediators | Cytokine levels will be studied in serum and in intestinal biopsies. Furthermore, a histological evaluation and the MPO activity will be studied in these biopsies and calprotectin levels will be determined in 'fecal' sampels. | 24 months |
| The expression of tight-junction associated proteins | The intestinal tight junctions-associated proteins will be studied by immune staining of intestinal biopsies and mRNA levels in intestinal biopsies using real time PCR. Biopsies will be collected from standardised locations. | 24 months. |
| D004066 |
| Digestive System Diseases |
| D007410 | Intestinal Diseases |
| D007077 | Ileal Diseases |
| D003092 | Colitis |
| D015212 | Inflammatory Bowel Diseases |
| D003108 | Colonic Diseases |